High prevalence of substance use disorders among adolescents who use marijuana and inhalants

被引:30
|
作者
Wu, LT
Pilowsky, DJ
Schlenger, WE
机构
[1] RTI Int, Ctr Risk Behav & Mental Hlth Res, Res Triangle Pk, NC 27709 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA
关键词
adolescents; alcohol use disorders; drug use disorders; inhalants; marijuana;
D O I
10.1016/j.drugalcdep.2004.08.025
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: We examined the association between the use of inhalants, marijuana, and other drugs and recent DSM-IV substance use disorders among adolescents aged 12-17 years. \ Methods: Data were drawn from 2000 to 2001 National Household Surveys on Drug Abuse. Adolescents aged 12-17 years who reported having ever used an illicit drug in their lifetime were categorized into four mutually exclusive groups: inhalant users (16%), marijuana users (53%), inhalant and marijuana users (16%), and other drug users (15%). Logistic regression models were used to estimate associations with recent substance use diagnoses among lifetime adolescent drug users (N= 10,180). Results: We found that 31% of lifetime drug users reported having never used marijuana. One half of these atypical drug users were predominantly nonmedical users of pain relievers. Adolescents who used inhalants or other drugs but not marijuana were least likely to report multidrug use. Adolescents who reported using both inhalants and marijuana were most likely to use three or more classes of drugs (73%) and to receive a diagnosis of past year alcohol (35%) and drug (39%) abuse or dependence. Conclusions: Our study findings suggest that among lifetime adolescent drug users, those who use both inhalants and marijuana are at very high risk for alcohol and drug use disorders. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 50 条
  • [31] The prevalence of the sleep disturbances among the patients with substance use disorders
    Vetrova, M. V.
    Kuchmenko, D. N.
    Genina, I. N.
    Goncharov, O., V
    Rybakova, K., V
    Semenova, N., V
    Zubova, E. Yu
    Kiselev, A. S.
    Neznanov, N. G.
    Krupitsky, E. M.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 26 - 35
  • [32] Prevalence of Substance Use Disorders by Time Since First Substance Use Among Young People in the US
    Volkow, Nora D.
    Han, Beth
    Einstein, Emily B.
    Compton, Wilson M.
    JAMA PEDIATRICS, 2021, 175 (06) : 640 - 643
  • [33] Prevalence and Attitudes Regarding Marijuana Use Among Adolescents Over the Past Decade
    Miech, Richard
    Johnston, Lloyd
    O'Malley, Patrick M.
    PEDIATRICS, 2017, 140 (06)
  • [34] Vulnerability for substance use disorders in adolescents
    Chen, Li-Ann
    Rao, Uma
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 9S - 9S
  • [35] Pharmacotherapy for Adolescents with Substance Use Disorders
    Courtney D.B.
    Milin R.
    Current Treatment Options in Psychiatry, 2015, 2 (3) : 312 - 325
  • [36] Adolescents at risk for substance use disorders
    Thatcher, Dawn L.
    Clark, Duncan B.
    ALCOHOL RESEARCH & HEALTH, 2008, 31 (02) : 168 - 176
  • [37] The effects of purchasing alcohol and marijuana among adolescents at-risk for future substance use
    Osilla, Karen Chan
    Pedersen, Eric R.
    Ewing, Brett A.
    Miles, Jeremy N. V.
    Ramchand, Rajeev
    D'Amico, Elizabeth J.
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2014, 9
  • [38] The effects of purchasing alcohol and marijuana among adolescents at-risk for future substance use
    Karen Chan Osilla
    Eric R Pedersen
    Brett A Ewing
    Jeremy NV Miles
    Rajeev Ramchand
    Elizabeth J D’Amico
    Substance Abuse Treatment, Prevention, and Policy, 9
  • [39] Substance Use Disorders in Children and Adolescents
    Nebhinani, Naresh
    Singh, Pranshu
    Mamta
    JOURNAL OF INDIAN ASSOCIATION FOR CHILD AND ADOLESCENT MENTAL HEALTH, 2022, 18 (02): : 128 - 136
  • [40] Substance use disorders among adolescents in Taiwan: prevalence, sociodemographic correlates and psychiatric co-morbidity
    Chong, MY
    Chan, KW
    Cheng, ATA
    PSYCHOLOGICAL MEDICINE, 1999, 29 (06) : 1387 - 1396